This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04400331
Brief Title: Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

First Submitted : May 19, 2020
First Submitted that Met QC Criteria : May 19, 2020
First Posted : May 22, 2020

Last Update Submitted that Met QC Criteria : October 31, 2023
Last Update Posted : November 2, 2023